You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

Citation Tools

Article menu
XML
Dermatology
Protocol
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Choon SE, Lebwohl MG, Marrakchi S, et al
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
BMJ Open 2021;11:e043666. doi: 10.1136/bmjopen-2020-043666